Death-associated protein kinase is a calcium/calmodulin serine/threonine kinase, which positively mediates programmed cell death in a variety of systems. Here we addressed its mode of regulation and identified a mechanism that restrains its apoptotic function in growing cells and enables its activation during cell death. It involves autophosphorylation of Ser 308 within the calmodulin (CaM)-regulatory domain, which occurs at basal state, in the absence of Ca 2؉ /CaM, and is inversely correlated with substrate phosphorylation. This type of phosphorylation takes place in growing cells and is strongly reduced upon their exposure to the apoptotic stimulus of C 6 -ceramide. The substitution of Ser 308 to alanine, which mimics the ceramide-induced dephosphorylation at this site, increases Ca 2؉ /CaM-independent substrate phosphorylation as well as binding and overall sensitivity of the kinase to CaM. At the cellular level, it strongly enhances the death-promoting activity of the kinase. Conversely, mutation to aspartic acid reduces the binding of the protein to CaM and abrogates almost completely the death-promoting function of the protein. These results are consistent with a molecular model in which phosphorylation on Ser 308 stabilizes a locked conformation of the CaM-regulatory domain within the catalytic cleft and simultaneously also interferes with CaM binding. We propose that this unique mechanism of auto-inhibition evolved to impose a locking device, which keeps death-associated protein kinase silent in healthy cells and ensures its activation only in response to apoptotic signals.
tor-␣, Fas, activated c-Myc, and detachment from extracellular matrix (1) (2) (3) (4) (5) . This microfilament-associated Ca 2ϩ /calmodulin (Ca 2ϩ /CaM)-dependent kinase has a unique multidomain structure that mediates protein-protein interactions such as ankyrin repeats and the death domain. The death-promoting effects of DAPK depend on its catalytic activity, the correct intracellular localization, and the presence of the death domain (2, 3) .
Interestingly, the expression of DAPK is frequently lost in cancer cell lines (6) . In some of these cell lines, aberrant DNA methylation was responsible for gene silencing. Analysis of the methylation status of DAPK 5Ј-untranslated region in DNA extracted from primary normal and tumor samples demonstrated frequent hypermethylation in B-cell malignancies (7), non-small cell lung carcinomas (8, 9) , head and neck cancer (10) , and thyroid lymphoma (11) . Furthermore, functional studies of experimental metastasis in syngeneic mice established a connection between loss of DAPK expression and formation of lung metastases (4) .
The structure/function dissection of the protein revealed two modules that inhibit the pro-apoptotic effect of DAPK. One comprises the CaM-regulatory segment, which possesses an auto-inhibitory effect on the catalytic activity, relieved by binding to Ca 2ϩ -activated CaM (2) . Consistently, the mere deletion of this segment from DAPK (⌬CaM mutant) generated a constitutively active kinase, which displayed CaM-independent substrate phosphorylation (using myosin light chain (MLC) as a substrate), and enhanced the apoptotic activity in vivo (2) . A second auto-inhibitory domain that affects the pro-apoptotic function of DAPK resides in its C-terminal serine-rich tail (12) . The molecular mechanism that may release the protein from auto-inhibition, leading to its activation has not yet been studied.
In addition to the common theme of CaM-mediated relief from auto-inhibition that characterizes the various CaM-regulated kinases (13, 14) , these kinases frequently possess a second layer of regulation, which is modulated by phosphorylation at specific sites. Both autophosphorylations and transphosphorylations by other kinases have been identified, differing in their position in the protein as well as in their effects on the catalytic activity. In several well studied cases, phosphorylation positively affects the enzymatic activity. For example, the catalytic activity of CaM-regulated protein kinase I (CaMKI) and IV (CaMKIV), is stimulated by another kinase, CaMK kinase, which phosphorylates a threonine residue residing within the activation loop in their catalytic domains (14 -16) . In another example, autophosphorylation of CaMKII on Thr 286 , residing in the CaM-regulatory domain, activates substrate phosphorylation by relieving the inhibitory effects of this re-gion (17) (18) (19) . This positive phosphorylation has previously been shown to be required for long term potentiation and learning capability in mice (20) . Positive autophosphorylation within the CaM-regulatory domain has also been documented in smooth muscle MLCK at Thr 803 (21) (22) (23) . Thus, distinct Ser/ Thr phosphorylations affect the kinase activity of these family members mostly by positive regulation.
In contrast, here we found that DAPK is negatively regulated by autophosphorylation. We identified a major autophosphorylation site on Ser 308 in the CaM-regulatory domain, which occurs at the basal state (absence of Ca 2ϩ /CaM) and is inversely correlated with substrate phosphorylation. This type of autophosphorylation takes place in vivo in growing cells and is strongly reduced by C 6 -ceramide treatment. Abrogation of phosphorylation by the substitution of Ser 308 with alanine generated a "gain of function" mutant of DAPK, which exerted super-killing activity in vivo, whereas the reversed mutation to aspartic acid weakened almost completely the death-promoting effects. At the biochemical level, the conversion to alanine increased both the basal Ca 2ϩ /CaM-independent catalytic activity as well as the binding of the enzyme to its activator, CaM, whereas the mutation to aspartic acid reduced very strongly these two different catalytic features. We propose a novel autoregulatory mechanism for DAPK in which autophosphorylation of Ser 308 serves as a locking device in the basal state. The autophosphorylation imposes charge-dependent interactions of the CaM-regulatory segment with the catalytic cleft and the ATP binding site, and lowers the susceptibility of the enzyme to activation by CaM by reducing the binding capacity of the enzyme to its activator, CaM. Dephosphorylation at this site relieves the protein from this mechanism of auto-inhibition and stimulates its pro-apoptotic functions.
MATERIALS AND METHODS
Plasmid Construction-DAPK expression vectors were prepared in pcDNA3 (Invitrogen). In all constructs, the DAPK sequence was tagged with the Flag epitope at the N terminus. The kinase domain (amino acids 1-319) was excised from full-length DAPK and was inserted into pcDNA3. Kinase domain mutants K42A (320) S308A (320) , S313A (320) , and S308/S313A (320) were generated by introducing point mutations to the wild-type kinase domain, using the QuikChange site-directed mutagenesis kit (Stratagene). The full-length DAPK mutants, S308A (f.l) and S308D (f.l) , were prepared by replacing a section in the full-length wild-type sequence with a sequence spanning the indicated point mutations.
Cell Lines and Transient Transfection-293 human embryonic kidney cells and HeLa cells were grown in Dulbecco's modified Eagle's medium (Biological Industries) supplemented with 10% fetal calf serum (Life Technologies, Inc.), 4 mM glutamine, 100 units/ml penicillin, and 0.1 mg/ml streptomycin. Transient transfections of 293 cells were done using calcium phosphate method as described previously (2, 3) . HeLa transfections were carried out with Superfect reagent (Qiagen).
Preparation of Cellular Extracts, Immunoprecipitation, and Western Blot Analysis-Extraction of the kinase domain was performed in lysis buffer (50 mM Tris, pH 8, 150 mM NaCl, 10% glycerol, and 1% Triton X-100) supplemented with a mixture of protease and phosphatase inhibitors (1 mM phenylmethylsulfonyl fluoride, 4 g/ml aprotinin, 100 g/ml leupeptin, 1.5 g/ml pepstatin A, 2 g/ml antipain, 2 g/ml chymostatin, 0.1 mM NaVO 3 , 10 mM NaPP i , and 0.1 mM NaF). Extraction of the full-length enzyme was performed in cold phosphate lysis buffer as described previously (2, 3) . For immunoprecipitation, the supernatants were incubated with anti-Flag monoclonal antibodies coupled to agarose beads (M 2 affinity gel; IBI Kodak) for 2 h at 4°C. Immunoprecipitated proteins were fractionated by SDS-PAGE, transferred to a nitrocellulose membrane and subjected to Western blot analysis using anti-FLAG monoclonal antibodies (IBI Kodak). Proteins were detected using the ECL detection reagent and autoradiography.
In Vitro Kinase Assay-DAPK constructs were immunoprecipitated from transfected 293 cells and washed twice with reaction buffer (50 mM Hepes, pH 7.5, 8 mM MgCl 2 , 2 mM MnCl 2 ). Samples were incubated for 8 min at 30°C in 30 l reaction buffer containing 9 Ci of [␥- where indicated, rabbit MLC (kindly provided by M. Gautel, MaxPlane-Institut, Dortmund, Germany). In all experiments the molar ratio between the different kinase forms and the substrate, MLC, did not exceed the 1:4 ratio. When indicated, 1 M bovine calmodulin (Sigma) and 0.5 mM CaCl 2 or 3 mM EGTA was added. Proteins were analyzed by 15% SDS-PAGE and transferred to a nitrocellulose membrane. Kinase activity (autophosphorylation and phosphorylation of MLC) was visualized by autoradiography of the 32 P-labeled proteins. To determine the levels of proteins in the samples, membranes were subjected to Western blot analysis using anti-Flag monoclonal antibodies. The band intensity was quantified by densitometric analysis.
CaM Overlay Assay-Equal amounts of immunoprecipitated Flagtagged kinase domain mutants were preincubated for 8 min at 30°C in kinase reaction buffer containing EGTA and ATP (but no MLC) for maximal autophosphorylation. Immunoprecipitated proteins were analyzed by 10% SDS-PAGE and transferred to a nitrocellulose membrane. The membrane was preincubated for 1 h in CaM binding buffer (50 mM Tris-HCl, pH 7.5, 150 mM NaCl, 1 mM CaCl 2 ) containing 10% nonfat dry milk powder. Following this blocking, recombinant 35 Slabeled calmodulin at 17 nM final concentration (generously provided by H. Frum, Weizmann Institute, Rehovot, Israel) was added, and the membrane was shaken gently at room temperature for 16 h, washed three times (5 min each) in calmodulin binding buffer, dried, and exposed to x-ray film. Flag-DAPK was detected on Western blots using anti-Flag antibodies and ECL.
Calmodulin Binding Assay-Equal amounts of immunoprecipitated Flag-tagged full-length DAPK mutants were incubated for 1.5 h at 30°C with 10, 100, and 1000 nM recombinant 35 S-labeled CaM in CaM binding buffer. The proteins were washed five times (15 min each) in calmodulin binding buffer, and 1 ml of scintillation fluid (Ultima Gold, Packard) was added to each point. The bound radioactivity was assessed by a standard ␤-counter (Packard). The ⌬CaM mutant, which lacks the CaM-binding region, served to assess the nonspecific background in these binding assays. Background radioactivity still present in the ⌬CaM DAPK mutant sample was subtracted from each tested sample.
Cell Death Assay-Transient transfections for apoptotic assays were done in six-well plates. For each well we used a mixture containing 1.7 g of DAPK pcDNA and 0.5 g of pEGFP plasmid (CLONTECH). Cells were counted 18 and 20 h after transfection. In each transfection, six fields, each consisting of 100 GFP-positive cells, were scored for apoptotic cell morphology. All the experiments were repeated at least three times. At the indicated time points, cell lysates were prepared from the transient transfections and the relative expression levels of each construct was determined by Western blotting.
In Vivo Analysis of Ser 308 Phosphorylation Status-HFB cells (HeLa cells carrying Fas receptors) were transfected with Flag-tagged WT (320) or S308A (320) and extracted with the above mentioned lysis buffer, which in addition includes 200 nM okadaic acid. The lysate was immunoprecipitated with anti-phosphoserine antibodies (Zymed Laboratories Inc.) (1:100). An aliquot of the cell extracts was left for determination of the relative amount of the recombinant proteins. The proteins were fractionated on 10% SDS-PAGE, transferred to nitrocellulose, and reacted with anti-Flag antibodies. To determine the effect of an apoptotic stimulus on Ser 308 phosphorylation, HFB cells transfected with WT (320) and S308A (320) were treated for the last 60 min before their harvest with C 6 -ceramide (40 M).
Molecular Modeling-The model structure of the kinase domain of DAPK was based on the x-ray structure of phosphorylase kinase in complex with a peptide substrate (Ref. 24 ; Protein Data Bank code 2phk); hence, the kinase is in a closed conformation. The characteristically conserved residues in the kinase domain were easily identified and used to verify the Psi Blast alignment of DAPK and phosphorylase kinase (25) . Hence, despite the low sequence identity (36%), a reliable model could be built except for a short positive segment (residues 45-55), which maps to a short helix in 2phk, although its sequence does not comply with a helical secondary structure. The model was constructed using the Homology module of MSI (MSI Inc., San Diego, CA). It was verified by calculating the three-dimensional/one-dimensional self-compatibility score (26) , which was 103.1 (the expected score for a protein of this length is 118.6). The electrostatic potential of the kinase domain was calculated using the program Delphi (27) with parameter for solvation energy charges and atomic radii (28) . The binding of the peptide to the kinase domain of DAPK was modeled in analogy to the binding of the peptide substrate to phosphorylase kinase.
To assess the effect of phosphorylation of Ser 308 on the binding to CaM, we constructed a model structure of the CaM-binding segment with CaM. To this end, we aligned the CaM-binding segment of DAPK with the corresponding segment of MLCK, whose structure in complex with CaM has been determined experimentally (Ref. 29 ; Protein Data Bank code 1cdl), and built the structure of the complex assuming that the overall conformation of the peptide-bound CaM molecule is not affected.
RESULTS
It has been shown previously that DAPK undergoes autophosphorylation (1), but the position of the phosphorylation sites and their possible functional relevance have not been addressed. Because the pro-apoptotic effect of DAPK depends on its catalytic activity, we asked whether any of these autophosphorylation sites may reside in the kinase domain and whether they provide an additional layer of regulation modulating the catalytic activity. To this end, a miniprotein spanning the catalytic and CaM-regulatory segments of DAPK was constructed (referred to as WT (320) ; see the scheme in Fig. 2 ). This protein was transiently expressed in 293 cells, immunoprecipitated with anti-Flag antibodies, and subjected to in vitro kinase assay performed either in the absence (EGTA) or presence of Ca 2ϩ /CaM. Both autophosphorylation and the phosphorylation of the external substrate MLC were assessed. For comparison, the full-length recombinant DAPK was subjected to a similar in vitro kinase assay. It was found that the kinase domain retained its ability to undergo autophosphorylation, thus confirming the presence of potential phosphorylation sites in this region. Surprisingly, however, and in contrast to the full-length protein, the kinase domain showed considerably lower levels of autophosphorylation in the presence of Ca 2ϩ / CaM than in its absence (Fig. 1, A and B) . As for MLC phosphorylation by WT (320), it was minimal in EGTA and was further stimulated by Ca 2ϩ /CaM, similar to substrate phosphorylation by the full-length protein. Thus, an inverse relationship between the autophosphorylation of the kinase domain and the phosphorylation of an external substrate was clearly documented. The reduced autophosphorylation was not dependent on the presence of MLC (data not shown), thus excluding possible substrate competition. This inverse relationship was not apparent when the full-length protein was assessed ( Fig. 1, A and B) , probably because of masking of these sites by additional sites along the noncatalytic segments of DAPK whose phosphorylation may instead be stimulated by Ca 2ϩ /CaM. We next proceeded to map the phosphorylation sites in the kinase domain. The catalytic segment by itself (referred to as WT (280) ; see scheme in Fig. 2 ), although retaining constitutive activity toward MLC, was not significantly autophosphorylated (data not shown), thus directing the subsequent mapping efforts toward the CaM-regulatory domain. This segment of DAPK contains several potential phosphorylation sites. Alignment of this stretch with the corresponding domains of other CaM-regulated kinases pointed out that Ser 308 and Ser 313 residues are conserved in the closely related DAPK homologue, DRP-1 (30) (Fig. 2 ) and in Caenorhabditis elegans DAPK (data not shown). To determine whether these two serines are targets for autophosphorylation by DAPK, a double mutant in which Ser 308 and Ser 313 were both converted to alanines was constructed. In vitro kinase assays revealed that this double mutant (referred to as S308/S313A (320) ) had lost most of its ability to undergo autophosphorylation in the presence of EGTA (Fig. 3, A and C) . This indicated that Ser 308 , Ser 313 , or both are the exclusive autophosphorylated residues in the kinase domain. Single mutations were then introduced individually into the kinase domain fragment (S308A (320) and S313A (320) , respectively). The conversion of Ser 308 to Ala resulted in the most profound effect, reducing autophosphorylation levels by 90% (Fig. 3, B and C) . In contrast, Ser 313 substitution had much milder, although statistically significant, effects on basal autophosphorylation (40% reduction on average; Fig. 3C ) and did not affect the Ca 2ϩ /CaM-induced decline (Fig. 3B) . Thus, the major site of autophosphorylation was mapped to Ser 308 in the CaM-binding domain. Next, we examined the effects of these mutations on MLC phosphorylation. It was found that elimination of the major phosphorylation site at Ser 308 resulted in elevation of basal MLC phosphorylation in the absence of Ca 2ϩ /CaM. This type of Ca 2ϩ /CaM-independent activity was observed both in the double mutant (Fig. 3, A and D) and the S308A (320) mutant (Fig.  3B) . In contrast, the S313A (320) mutant did not differ from the wild type fragment and displayed low basal activity toward MLC in the absence of Ca 2ϩ /CaM (Fig. 3B) . Thus, it appears that mutation at Ser 308 , which eliminated most of the autophosphorylation, partially released the kinase domain from the strict auto-inhibition imposed by the CaM-regulatory region. Still, the overall responsiveness to CaM was retained, as S308A/S313A (320) (Fig. 3, A and D) and S308A (320) (Figs. 3B  and 4A ) fragments reached the same maximal levels of activity in the presence of high concentrations (1 M) of Ca 2ϩ /CaM. Testing MLC phosphorylation at low CaM concentrations (e.g. 10 Ϫ1 nM) highlighted a second feature, which was acquired by the Ser to Ala mutation. Although the wild type fragment was refractory to these low CaM levels, the S308A (320) mutant displayed prominent elevations in MLC phosphorylation over the high basal levels (Fig. 4A) . The ability of S308A (320) to respond to lower CaM concentrations than the WT form was observed repeatedly (p Ͻ 0.01). CaM concentration curves indicated 100-fold relative shift in the CaM activation constant (data not shown). Of note, the elevated basal activity of S308A in the presence of EGTA reflects the mere CaM-independent activity rather than a response to low CaM levels, which may contaminate the MLC preparation. That is because CaM, even at high concentrations, has no effect in the absence of Ca 2ϩ (i.e. in the presence of EGTA), both in the WT and S308A mutant form.
The higher response of S308A (320) to CaM opened up a series of experiments where the binding activity of the kinase domains to recombinant CaM was directly tested. To this end, a CaM overlay assay was performed, in which the different mutants were compared for their ability to bind radiolabeled CaM on immunoblots. It was found that S308A/S313A (320) and S308A (320) mutants each displayed higher CaM binding capability than the wild type kinase domain or the S313A (320) mutant (Fig. 4B) . Thus, by mimicking the dephosphorylated state on Ser 308 with the alanine mutation, the binding capability to CaM was clearly increased. Next, the effect of the single mutation was examined in the context of the full-length protein.
To this end, Ser 308 within the full-length protein was substituted either to Ala or to Asp, thus mimicking dephosphorylated or fully phosphorylated states at position 308, respectively (referred to as S308A (f.l) and S308D (f.l) ). In experiments where the proteins were incubated with increasing concentration of 35 S-labeled CaM, S308D (f.l) displayed considerably low CaMbinding capability as detected under all tested CaM concentrations (10 -1000 nM). Conversely, the substitution to alanine increased the binding capability compared with WT (f.l) as mainly detected at the 10 nM and 100 nM CaM concentrations (Fig. 4C) . Additionally, as seen with the short fragment, the substitution to alanine also elevated the Ca 2ϩ /CaM-independent MLC phosphorylation, whereas the mutation to aspartic acid minimized it (Fig. 4D) . Thus, prevention of phosphorylation on Ser 308 within the full-length enzyme promotes Ca 2ϩ / CaM-independent activity and the binding to its activator, CaM, whereas the presence of a negative charge on the same site acts to down-regulate these two properties, suggesting that phosphorylation inhibits different aspects of the catalytic activity.
Once the biochemical relevance of Ser 308 phosphorylation was established in vitro, it was important to find out whether it also occurs in vivo in growing cells and whether this site is subjected to dephosphorylation as part of the kinase activation during apoptosis. To this end, Flag-tagged WT (320) protein was immunoprecipitated from HeLa cells with anti-phosphoserine antibodies to trace the phosphoprotein. (An aliquot of the cell extracts was left for the determination of the relative amount of recombinant proteins.) The S308A (320) mutant was similarly immunoprecipitated from cells to assess the contribution of Ser 308 phosphorylation to the total signal detected in the WT (320) protein by the anti-phosphoserine antibodies. It was found that the anti-phosphoserine antibodies efficiently recognized the WT (320) under these conditions, whereas the mutant (320) , and S308/S313A (320) after 8 min of in vitro autophosphorylation in the absence of Ca 2ϩ /CaM were determined. Levels of autophosphorylation were measured and normalized according to protein levels. The results are the average of three independent autophosphorylation assays; the small difference between S308A and the double mutant is statistically significant (p ϭ 0.001). D, levels of MLC phosphorylation, shown in A, were quantified as described under "Materials and Methods." S308A (320) gave rise to a significantly lower signal (Fig. 5A ). This finding indicated that Ser 308 is phosphorylated in growing cells and that the general anti-phosphoserine antibodies could serve as a tool to monitor Ser 308 phosphorylation state in vivo. Immunoprecipitation of a catalytically inactive kinase domain (K42A (320) ) with the anti-phosphoserine antibodies also gave rise to a low signal in comparison to WT (320) (Fig. 5B) . This indicated that phosphorylation of Ser 308 in vivo results from autophosphorylation and not from transphosphorylation by another kinase.
Next we followed the fate of Ser 308 phosphorylation in response to an apoptotic trigger. HFB cells transfected with WT (320) or S308A (320) responded to treatment with C 6 -ceramide (40 M) in a fast and well synchronized cell death process. As early as 30 min after treatment, cells rounded up and membrane blebbing took place. Within 1 h of C 6 -ceramide treatment, most of the cells in the population displayed this characteristic apoptotic morphology. The rapid and synchronized kinetics of the apoptotic response of the cells to C 6 -ceramide makes it an ideal system for studying DAP-kinase regulation. The treated cells were harvested after 60 min and subjected to anti-phosphoserine immunoprecipitation procedure as before. An aliquot of the cell extracts was left for determination of the relative amount of the recombinant proteins. There was a marked reduction in the amount of WT (320) immunoprecipitated by the anti-phosphoserine antibodies upon C 6 -ceramide treatment, whereas the total levels of the protein did not change (Fig. 5A) . Interestingly, the quantity of WT (320) recovered upon C 6 -ceramide treatment was similar to the unphosphorylatable S308A (320) mutant form in growing cells. The latter was unaffected by C 6 -ceramide treatment (Fig. 5A) , further establishing the specificity of the C 6 -ceramide effect toward Ser 308 . Thus, Ser 308 is autophosphorylated in growing cells and is dephosphorylated in response to the apoptotic stimulus of C 6 -ceramide.
Next, we assessed the functional significance of the phosphorylation status of serine 308 at the cellular level. This was achieved by comparing the death-inducing properties of the full-length wild type protein to the two opposite point mutations. To this end, 293 cells were transiently transfected with WT (f.l) , S308A (f.l) , or S308D (f.l) together with GFP, and the transfected GFP-positive cells were scored for apoptotic morphology. Overexpression of the full-length wild type protein resulted in 42% cell death, consistent with previous reports (2) . Cells displayed the apoptotic morphology typical of DAPK including cell shrinkage and rounding, and membrane blebbing, followed by detachment of cells from plate. Interestingly, the mutation of Ser 308 to alanine (S308A (f.l) mutant) increased very significantly the pro-apoptotic effects of the protein, resulting in massive cell death (ϳ90% apoptotic cells; Fig. 5, C and D, left  panel) . The values were similar to the extent of cell death induced by the gain of function mutant ⌬CaM, in which the entire CaM-regulatory segment has been deleted, suggesting that the mutation was extremely efficient in negating the inhibitory effect of this segment at the cellular level. Conversely, the mutation of Ser 308 to aspartic acid reduced the death-
FIG. 4. Prevention of autophosphorylation on Ser 308 results in partial Ca
2؉ /CaM-independent activity and elevated affinity to CaM. A, the mutation of Ser 308 to alanine renders the enzyme more susceptible to activation by CaM. Equal amounts of WT (320) and S308A (320) were preincubated with EGTA and cold ATP for 16 min to allow maximal Ca 2ϩ /CaM-independent autophosphorylation before substrate addition, and thereafter MLC phosphorylation was assessed with different CaM concentrations under the usual in vitro kinase assay conditions. The results are the average of three independent experiments. B, WT (320) , S308A (320) , S313A (320) , and S308/S313A (320) were assayed in vitro for their CaM binding activity by CaM overlay assay. Proteins were preincubated for 8 min in the presence of EGTA and cold ATP for maximal autophosphorylation, analyzed by 10% SDS-PAGE, and transferred to a nitrocellulose membrane. Membrane was incubated with [
35 S]methionine-labeled recombinant CaM (upper panel). Lower panel shows the same blot with anti-FLAG antibodies to evaluate the relative amount of each of the miniproteins. C, binding affinity to CaM of full-length DAPK protein is affected by the single amino acid substitutions. WT (f.l) , S308A (f.l) , and S308D (fl) DAPK constructs were transfected into 293 cells and immunoprecipitated with anti-Flag antibodies. Equal amounts of the various full-length DAPK mutants were then subjected to CaM binding assay with 10, 100, and 1000 nM 35 S-labeled CaM as described under "Materials and Methods." The results are the average of three independent experiments. D, rabbit MLC phosphorylation by full-length DAPK: wild-type (WT (f.l) ) and the Ser 308A mutants (S308A (f.l) and S308D (f.l) ), in the presence or absence of Ca 2ϩ /CaM. The bars provide the densitometric values of MLC phosphorylation of three independent experiments, quantified as described under "Materials and Methods" and normalized according to protein levels.
inducing activity of the enzyme, as compared with the wild type protein, resulting in only 12% apoptotic cells (Fig. 5, C and D,  right panel) . All the recombinant proteins were expressed in the cells to the same extent (Fig. 5C) . Thus, prevention of autophosphorylation within the CaM-regulatory domain by serine to alanine substitution results in a very strong gain of function mutation, which converts the full-length protein into a super-killer form. In contrast, the presence of a negative charge at position 308, mimicking the phosphorylated state, diminishes the pro-apoptotic activity of the enzyme.
DISCUSSION
The apoptotic function of DAPK must be under tight control, to ensure, on one hand, its silence under normal growth conditions and to allow, on the other hand, rapid activation in response to the appropriate apoptotic signal. Although extensive work was invested in characterizing the apoptotic systems where DAP kinase functions, in dissecting structure/function features of the protein, and in analyzing the impact of its loss in cancer development (1-6), the mechanism of DAP kinase activation has been so far poorly addressed. Here we describe for the first time a mechanism of autophosphorylation that imposes a safety device on the catalytic activity of DAP kinase, and consequently, restrains its pro-apoptotic functions. Moreover, this site is dephosphorylated upon the apoptotic stimulus of C 6 -ceramide, suggesting that it becomes a target for regulation when the pro-apoptotic function of DAPK must be turned on.
The functionally relevant autophosphorylation site was mapped in this study to Ser 308 , which resides within the CaMregulatory segment of the enzyme. The autophosphorylation of Ser 308 was found to be Ca 2ϩ /CaM-independent; moreover, it was strongly inhibited by the addition of Ca 2ϩ /CaM. These findings are consistent with the predicted three-dimensional structures and actual crystal structure of a few CaM-regulated kinases, which show that the CaM-regulatory segment is positioned at the catalytic cleft in the basal state, but is removed upon binding to CaM (14, 17, (31) (32) (33) . A model structure of the catalytic domain of DAPK was constructed based on the x-ray structure of phosphorylase kinase in complex with a substrate peptide (Ref. 24 ; Protein Data Bank code 2phk). As shown in Fig. 6A , in this model structure, Ser 308 is localized within the catalytic cleft of the enzyme, at a distance that allows the proper phosphotransfer step. This is consistent with our experimental data, which showed that mutation at position 308 eliminated more than 90% of total autophosphorylation. In contrast, the position of Ser 313 in this model is not compatible with a direct autophosphorylation on this site. The mild effects that resulted from the mutation of this site could indicate that Ser 313 serves as a second site in the CaM-binding segment whose phosphorylation depends on prior Ser 308 autophosphorylation. Alternatively, this serine may not be a target for phosphorylation, but the presence of side chain of this amino acid may indirectly influence the extent of Ser 308 autophosphorylation. Obviously, direct assessments of phosphate residues by mass spectrometric analysis should be done to resolve this issue in the future. Either way, because the mutation in Ser 313 did not significantly affect the biochemical properties of the enzyme, it is presently considered as secondary in its functional importance.
In addition to the in vitro phosphorylation assays, we show in this work that the enzyme is autophosphorylated on residue 308 in growing cells and is subjected to dephosphorylation in response to ceramide. The functional relevance of the phosphorylation status within this specific site was established here by single point mutations. The S308D substitution, mimicking phosphorylation and simulating the state of DAPK in growing cells, gave rise to a "loss of function" mutant, which possesses very minor killing activity. In contrast, S308A representing imposed dephosphorylation, and simulating the state of DAPK in response to an apoptotic stimulus, generated a gain of function super-killer mutant. Thus, phosphorylation on Ser 308 silences the pro-apoptotic activity, whereas dephosphorylation of Ser 308 is part of the activation process of DAPK. Biochemical analysis of these mutants revealed two distinct properties, which are influenced by the phosphorylation status of serine 308. The first was an elevated basal Ca 2ϩ /CaM-independent catalytic activity upon dephosphorylation (Ser to Ala substitution). This Ca 2ϩ /CaM-independent activity was minimized by the Ser to Asp substitution. It is suggested that Ser 308 autophosphorylation strengthens a "locking device," probably generated by the interaction of the CaM auto-inhibitory domain with the catalytic cleft. Absence of the phosphate group, conversely, weakens this "lock" and therefore partially relieves the auto-inhibition, resulting in Ca 2ϩ /CaM-independent activity. In fact, the molecular model shown in Fig. 6A predicts that the peptide derived from the CaM-regulatory region binds in the active site, with Ser 308 -PO 3 positioned next to the ATP binding P-loop, such that the phosphate moiety interacts favorably with this loop and with the positively charged Lys 141 . Thus, the ionic interactions between these residues may stabilize the phosphorylated CaM-regulatory domain in a locked position in the catalytic cleft.
The second outcome of preventing Ser 308 phosphorylation was the elevated binding to Ca 2ϩ /CaM, which was counteracted by the opposing substitution to aspartic acid. The elevation could result from enhanced accessibility of the dephosphorylated form to interaction with CaM as a result of "weakened lock" and/or from an intrinsic property of the dephosphorylated segment, which permits a better interaction with CaM. In agreement with the second option, a molecular model simulating the interaction between the CaM binding segment of DAPK and Ca 2ϩ /CaM predicts Ser 308 to lie within a mostly hydrophobic cleft of CaM (Fig. 6B) . According to this model, CaM would favor binding to the form that lacks the negatively charged phosphoryl group.
We propose a mechanism in which autophosphorylation at the basal state serves as a locking device, ensuring the activation of the kinase only upon the appropriate apoptotic signal. The localization of Ser 308 within the catalytic cleft promotes its phosphorylation and, by that means, simultaneously reinforces the existing "locked" conformation and decreases the chances that the enzyme will be activated by random fluctuations in cellular Ca 2ϩ levels. Upon triggering of death signals by the addition of C 6 -ceramide, the restrains imposed by the negative autophosphorylation of Ser 308 are removed. This may be achieved by Ser 308 dephosphorylation by a specific phosphatase, the identity of which is yet unknown. The dephosphorylation state results in a highly active enzyme with enhanced cell killing capacity. We propose now that this super-killing activity emerges from increased CaM-independent activity of the kinase as a result of weakened lock and increased binding activity to CaM, which facilitates its full activation even at low Ca 2ϩ /CaM levels. This enhanced sensitivity to suboptimal levels of Ca 2ϩ /CaM could potentiate the response of DAPK to the Ca 2ϩ spike that takes place during cell death and could also serve to widen the window of DAPK activation beyond the time where intracellular Ca 2ϩ levels are maximal. Phosphorylation events within the CaM-binding segments that reduce the affinity of a kinase to CaM were observed previously in CaMKII at either Thr 305 or Thr 306 . However, although DAPK phosphorylation occurs at the basal state and serves as a mechanism to block the enzyme activity in healthy cells, CaMKII phosphorylation at Thr 305 and Thr 306 is a secondary event that follows the positive CaM-dependent phosphorylation in Thr 286 (34, 35) . At basal state, in the absence of Thr 286 phosphorylation, the rate of this negative autophosphorylation process is extremely low and its functional relevance is not clear (36) . Another example of inhibitory autophosphorylation was recently found in DRP-1, a close relative of DAP kinase. This short kinase displays 80% identity with DAP kinase catalytic and CaM-regulatory domains, whereas its extra-catalytic domain differs completely constituting a short C-terminal tail required for homodimerization (37) . Because of the high degree of homology within the catalytic and CaMregulatory domains, the precise site of autophosphorylation has been conserved in these two kinases. However, the structural differences between the two proteins dictates a significant variation in the functional outcome of these phosphorylation. For instance, in DRP-1, the autophosphorylation restricts homodimerization, which is critical for the cellular functions of this kinase (37) .
Several questions are still open. The first relates to the identity and mode of activation by C 6 -ceramide of the putative phosphatase that releases DAPK from this auto-inhibitory phosphorylation. Another issue relates to the identification of additional autophosphorylation sites, which are located outside the catalytic domain, that are stimulated by Ca 2ϩ /CaM (Fig. 1) . These other autophosphorylation sites may reside in one or more of the multiple motifs and domains present in DAPK, and may affect additional properties of DAPK, such as interaction with other proteins, intramolecular folding, or intracellular localization. Further efforts should be invested to map precisely the position of the additional autophosphorylation sites, and to determine their relevance to the pro-apoptotic functions of DAPK.
